CordenPharma Acquires AmbioPharm to Expand Global Peptide API Capacity
Acquisition strengthens U.S. peptide manufacturing capabilities and broadens global expertise in complex peptide APIs CordenPharma has entered into an agreement to acquire AmbioPharm, a U.S.-headquartered peptide CDMO with facilities in North...